LifeSpan and MBL Announce Multi-Year Licensing and Asset Agreement
News Feb 22, 2006
LifeSpan BioSciences, Inc. and MBL International Corporation, a wholly owned subsidiary of Medical and Biological Laboratories Co., Ltd. (Nagoya, Japan), have announced a multi-year relationship in which MBLI will distribute antibodies to druggable gene targets that LifeSpan has developed and commercialized.
As part of the new relationship, MBLI has purchased LifeSpan’s existing inventory of 900 antibodies including the exclusive research reagent sales rights.
Dennis Walczewski, chief executive officer of MBLI said, "The relationship with LifeSpan addresses the needs of both organizations."
"The products and technology obtained from LifeSpan complement our existing product lines, increasing our product offering to over 4,000 products. LifeSpan and MBLI feel that this relationship will help both companies meet the future needs of the scientific research community."
Dr. Joseph Brown, president and CEO of LifeSpan said, "This partnership with MBLI is an important milestone in LifeSpan’s long term strategy to become a global provider of Molecular Pathology products and services, including reagent antibodies to the genes most important in finding new treatments for disease."
"Moreover, it gives LifeSpan new resources to fund additional development within our core business."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
You Are What Your Mother EatsNews
While many factors, such as the age of the mother, overall health and genetics ultimately play a role, the correlation between a mother’s nutrition habits and metabolism has been proved to directly impact the growth of her child. And researchers believe they may be one step closer to knowing why.READ MORE